Search Results - Evan J. Lipson

Refine Results
  1. 1
    Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma

    Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma by Evan J. Lipson, Charles G. Drake

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer

    Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer by Charles G. Drake, Evan J. Lipson, Julie R. Brahmer

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Immunotherapy for Merkel cell carcinoma: a turning point in patient care

    Immunotherapy for Merkel cell carcinoma: a turning point in patient care by Isaac S. Chan, Shailender Bhatia, Howard L. Kaufman, Evan J. Lipson

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma

    Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma by Evan J. Lipson, Mabel A. Bodell, Edward S. Kraus, William H. Sharfman

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis

    Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis by Animesh Jain, Evan J. Lipson, William H. Sharfman, Steven R. Brant, Mark Lazarev

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation by Rita E Morales, Alexander N. Shoushtari, Michelle M. Walsh, Priya Grewal, Evan J. Lipson, Richard D. Carvajal

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Antagonists of PD-1 and PD-L1 in Cancer Treatment

    Antagonists of PD-1 and PD-L1 in Cancer Treatment by Evan J. Lipson, Patrick M. Forde, Hans-Joerg Hammers, Leisha A. Emens, Janis M. Taube, Suzanne L. Topalian

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade

    Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade by Evan J. Lipson, Victor E. Velculescu, Theresa S. Pritchard, Mark Sausen, Drew M. Pardoll, Suzanne L. Topalian, Luis A. Díaz

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

    Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade by Evan J. Lipson, Mohammed Lilo, Aleksandra Ogurtsova, Jessica Esandrio, Haiying Xu, Patricia Brothers, Megan D. Schollenberger, William H. Sharfman, Janis M. Taube

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat

    Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat by Erin E. Resch, Stavriani C. Makri, Paola Ghanem, Ezra Baraban, Kenneth J. Cohen, Alan R. Cohen, Evan J. Lipson, Christine A. Pratilas

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer

    Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer by T.J. Williams, David Benavides, Kelly-Ann Patrice, Josep Dalmau, Alexandre Avila, Dung T. Le, Evan J. Lipson, John C. Probasco, Ellen M. Mowry

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

    Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series by Jaclyn LoPiccolo, Megan D. Schollenberger, Sumia Dakhil, Samuel Rosner, Osama Ali, William H. Sharfman, Ann W. Silk, Shailender Bhatia, Evan J. Lipson

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen

    Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen by Laura C. Cappelli, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Lei Zheng, Clifton O. Bingham, Ami A. Shah

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Tumor Regression and Allograft Rejection after Administration of Anti–PD-1

    Tumor Regression and Allograft Rejection after Administration of Anti–PD-1 by Evan J. Lipson, Serena M. Bagnasco, Jack Moore, Sekwon Jang, Manisha J. Patel, Andrea A. Zachary, Drew M. Pardoll, Janis M. Taube, Charles G. Drake

    Published 2016
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  15. 15
    Cardiovascular toxicities associated with immune checkpoint inhibitors

    Cardiovascular toxicities associated with immune checkpoint inhibitors by Jiun‐Ruey Hu, Roberta Florido, Evan J. Lipson, Jarushka Naidoo, Reza Ardehali, Carlo G. Tocchetti, Alexander R. Lyon, Robert F. Padera, Douglas B. Johnson, Javid J. Moslehi

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

    Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy by Lucie Heinzerling, Patrick A. Ott, F. Stephen Hodi, Aliya N. Husain, Azadeh Tajmir-Riahi, Hussein A. Tawbi, Matthias Pauschinger, Thomas F. Gajewski, Evan J. Lipson, Jason J. Luke

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

    Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series by Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma

    Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma by Steve Y. Cho, Evan J. Lipson, Hyung‐Jun Im, Steven P. Rowe, Esther Mena Gonzalez, Amanda L. Blackford, Alin Chirindel, Drew M. Pardoll, Suzanne L. Topalian, Richard L. Wahl

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

    Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation by Tawnie Braaten, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Megan D. Schollenberger, Lei Zheng, Clifton O. Bingham, Ami A. Shah, Laura C. Cappelli

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival

    PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival by Evan J. Lipson, Jeremy Vincent, Myriam Loyo, Luciane T. Kagohara, Brandon Luber, Hao Wang, Haiying Xu, Suresh K. Nayar, Timothy S. Wang, David Sidransky, Robert A. Anders, Suzanne L. Topalian, Janis M. Taube

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: